OPIOID OVERDOSE PREVENTON

Size: px
Start display at page:

Download "OPIOID OVERDOSE PREVENTON"

Transcription

1 1 OPIOID OVERDOSE PREVENTON Zena Hyman, DNS, ANP-BC October 4, Special Thanks and Recognition to: Office of Alcoholism and Substance Abuse Services New York State Department of Health Harm Reduction Coalition PART ONE EPIDEMIOLOGY 1

2 4 Heroin Overdose Deaths (prior to 2006) About 2% of heroin users died each year- many from heroin overdose : 5,506 deaths in NYC Average of 1-2/day in NYC Up to 2/3 of heroin users experience at least one nonfatal overdose 2006: 979 OD deaths in NYC (70% due to opioids) = ~ 685 opioid deaths Coffin, 2007; Galea, 2003; Sporer, HRC Overdose Rates Increase 5 Between 2002 and 2013, heroin-related overdose deaths nearly quadrupled. Greater than 8,200 people died in 2013, with higher rates in the Northeast and Midwest. CDC, 2015 Top Medicines by Prescriptions (IMH, National Prescription Audit, Dec., 2011) Name Hydrocodone/acetaminophen Levothyroxine sodium Alprazolam Oxycodone/acetaminophen Tramadol HCL

3 Drug Trend in the U.S.: Opioid Epidemic Rx Opioid availability Rx Opioid exposure Rx Opioid misuse IVDU/Heroin ) OVERDOSE DEATHS IN NYC INVOLVING MULTIPLE DRUGS (2008) HRC Nearly all unintentional drug overdose deaths (98%) involve more than one substance, including alcohol. Opioids were the most commonly noted drug type (74%). Types of opioids included heroin, methadone, and prescription pain relievers. (No mention of fentanyl.) Other drugs commonly found were: cocaine (53%), benzodiazepines (35%), antidepressants (26%), and alcohol (43%). Consider trends in drugs over time. NYC VITAL SIGNS Volume 9, No. 1, NYCDOHMH 3

4 10 Who overdoses? 11 Historically users with 5-10 years of experience (Sporer, 2003, 2006) Past hx OD, male gender, sexual abuse, pain (Britton, Wines, Connerb, 2009). Fatal OD are common in older individuals (CDC, 2011) and individuals prescribed immediate release formulations (Hirsh, Proescholdbell, Bronson, Dasgupta, 2014). Unstable housing, serious illness, Drug poisoning death rates by age: United States, and over CDC/NCHS, National Vital Statistics System; and Warner M, Chen LH, Makuc DM, Anderson RN, Miniño AM. Drug poisoning deaths in the United States, NCHS data brief, no 81. Hyattsville, MD: National Center for Health Statistics Intercensal populations 4

5 Loss of Tolerance Regular use of opioids leads to greater tolerance, i.e., more needed to achieve the same result Overdose occurs often when people start using again following a period of not using (abstinence) Common situations leading to loss of tolerance include: Incarceration, detox, Drug Free treatment, or self imposed breaks from use Take Away: Tolerance can decrease in as little as 72 hours MIXING DRUGS Nearly all people who used heroin also used at least 1 other drug. Most used at least 3 other drugs (NSDUH, ). Mixing opioids with other drugs, especially depressants such as benzodiazepines or alcohol can lead to an overdose. Most OD occur in 1-3 hours but the peak action and duration of the substances influence the sequence. GUIDANCE FOR PATIENTS Don t use alone or tell someone to check in on you Don t mix drugs Know the strength or purity of what you are using Don t be greedy 5

6 PART TWO PHARMACOLOGY Opioids (Lagos,2008) FULL morphine oxycodone fentanyl PURE naloxone naltrexone tramadol PARTIAL butorphanol pentazocine buprenorphine nalbuphine 17 AMSP OPIOIDS Fully Synthetic OPIATES Lagos, 2008) Bind to opioid receptors Morphine-like action DSM-IV: OPIOIDS 18 AMSP 6

7 Opioid Receptors µ (mu): Activated by morphine: analgesia Primary action site of all opioids Distribution: CNS and GI Linked to abuse/dependence κ (kappa): analgesia, endocrine changes and dysphoria δ (delta): for endogenous peptides 19 AMSP (Lagos,2008) PHARMACODYNAMICS 20 Desirable Analgesia Cough suppressant Antidiarrheal Inhibit peristalsis Undesirable Euphoria Decrease respiration Sedation Endocrine effects Constipation PHARMACOKINETICS ARE VARIABLE ROUTES OF ADMINISTRATION Swallowed whole or crushed Crushed and snorted Crushed and smoked, inhaled Crushed, dissolved, and injected Sublingual, buccal, recital, vaginal Transdermal, spinal, intrathecal, epidural 7

8 Physiology of an Overdose 22 Opioid receptors are found in the brain, including the respiratory center in the medulla Opioid overdose Represses the urge to breathe Decrease response to carbon dioxideleads to respiratory depression Death Overdose Opioid overdose is preventable and, if witnessed, treatable (reversible) (WHO, 2013). Generally happens over a period of 1 3 hours where there is suppression of the urge to breath and oxygen levels fall below the level needed to transfer oxygen to vital organs. Non-fatal overdose leads to brain damage, cardiac arrhythmia, pulmonary edema. Fatal overdose occurs with cessation of breathing. HOW NALOXONE WORKS OPIOIDS, AGONISTS BIND TO THE RECEPTORS NALOXONE, ANTAGONIST DISPLACES OPIOIDS OFF RECEPTORS Naloxone temporarily holds receptors, time varies depending on the opioid OPIOID OPIOID OPIOID OPIOID OPIOID OPIOID NALOXONE NALOXONE NALOXONE 24 OPIOID RECEPTORS IN THE BRAIN 8

9 NALOXONE IN ACTION 25 Reverses opiate effects of sedation and respiratory depression Causes sudden withdrawal unpleasant feeling Lowers potential for abuse not addictive Wakes the person who is overdosing in 3-5 minutes Work for approx., minutes Analogy: wrong key stuck in a lock Safe, highly effective Routinely used by EMS (larger doses) No harm if an opioid is not present Sold over the counter in Italy since 1988 No potential for abuse 26 Adverse Reactions Related to Withdrawal Sympathetic excess- cardiovascular, CNS Reversal opioid analgesia and sedation- CNS, neuromuscular and skeletal excitement, restlessness Increased gastrointestinal motility 9

10 28 29 OVERDOSE RESCUE KIT 30 Intramuscular (IM) Naloxone 2 safety syringes 2 vials of Naloxone Alcohol swabs Intranasal (IN) Naloxone 2 Luer-Lock pre-filled syringes 2 doses of Naloxone (Narcan ) 10

11 Con t: OVERDOSE RESCUE KIT 31 In addition, both kits are supplied with: A face mask for rescue breathing 2 latex gloves Directions for administering IM and intranasal Program contact information to seek refills, etc. Drug treatment/counseling resources (as per PH Law Section 3309, 10 NYCRR ) Taking care of naloxone 32 Storage: o Attach naloxone to delivery device when ready to use. o Store naloxone in original package at room temperature; avoid exposure to light. o Keep in a safe place away from children & pets, but easy to access in case of emergency. Expiration: o Naloxone loses its effectiveness over time. o DoD data indicate naloxone is hardier than manufacture guidance. Opioid maintenance and mortality Overdose deaths in Baltimore Adjusting for heroin purity and the number of methadone patients, there was a statistically significant inverse relationship between heroin overdose deaths and patients treated with buprenorphine (P =.002). Schwartz et al AJPH

12 Overdose Prevention Programs that distribute naloxone: survey of programs known to the Harm Reduction Coalition 189 local programs in 16 states ranging from statefunded to underground : 53,339 individuals received kits 10,194 overdose reversals reported CDC MMWR February 17, PART THREE HISTORY AND THEORETICAL FRAMEWORK History Since the 1996 community-based programs have offered opioid overdose prevention services to persons who use drugs, their families and friends, and service providers. NYS legislation and regulations have passed giving sanction to overdose prevention programs and protection to Samaritans who respond to an overdose. During , these programs reported training and providing naloxone kits to 53,032 persons, resulting in 10,171 drug overdose reversals using naloxone Wheeler et al., 2012, Community-based opioid overdose prevention programs providing naloxone: United States, 2010, Morbidity and Mortality Weekly Report, 61( 6), p

13 Headlines Decline in Drug Overdose Deaths After State Policy Changes Florida, MMWR July 4, 2014 / 63(26); THEORETICAL CONCEPTS: DIFFUSION OF INNOVATIONS Diffusion: process by which an innovation is communicated through certain channels over time among the members of a social system (Rogers, 2003). Innovation: an idea, practice, or object perceived as new by an individual or other unit of adoption. Diffusion Process: involves mass media and interpersonal, communication channels. CHARACTERISTICS OF AN INNOVATION (ROGER CLARK, 1991, 1994, 1999) Relative advantage - the degree to which it is perceived to be better than what it supersedes Compatibility - consistency with existing values, past experiences and needs Complexity - difficulty of understanding and use Trialability - the degree to which it can be experimented with on a limited basis Observability - the visibility of its results 13

14 CONCEPTS OF PREVENTION Primary Prevention aims to decrease incidence and prevalence of a disease. (Protection) Secondary Prevention aims to discover disease before the development of symptoms and to intervene before consequences occur. (Screening) Tertiary Prevention aims to prevent further damage from occurring as a consequence of disease. What is NYS s Opioid Overdose Program? 41 April 2006, PHL Section 3309, 10 NYCRR Eligible, registered entities provide training to individuals in the community on how to respond to an overdose Health care facilities Drug treatment programs Health care practitioners (MD, DO, NP, PA) Community-based organizations Local health departments Police and EMT Colleges, universities and trade schools Local and state agencies Pharmacies 42 New York State s Good Samaritan law Sept. 18, 2011 Protects: Individual who experience an overdose Person who summons EMS (calls 9-1-1) Protections from: Arrest in the presence of misdemeanor possession and/or underage drinking Prosecution in felony possession 14

15 More on Good Samaritan 43 Offers protection from charge and prosecution for possession of: Drugs up to an A2 felony offense (possession of up to 8oz of narcotics); Alcohol (for underage drinkers); Marijuana (any amount); Paraphernalia offenses; Sharing of drugs (in NYS sharing constitutes a sales offense). Limitations 44 Does not offer protection for drug offenses involving: Sales for consideration or other benefit or gain People in possession of A1 felony amounts of narcotics (not marijuana), meaning 8oz or more of narcotics Arrest or charge for drug or alcohol possession for individuals with an open warrant for their arrest Parole is neither expressly covered or singled out for non-coverage. Parole encourages carrying kits and use is not necessarily a violation 45 Logistics and Paperwork 15

16 All trainings will address at a minimum (NYSDOH) Risk factors for opioid overdose: Loss of tolerance Mixing drugs Using alone Signs of an overdose: Lack of response to sternal rub Shallow or no breathing Bluish lips or nail beds Actions: Call 911 Rescue breathing Using naloxone Rescue position Brief education increases recognition of OD among heroin users. (Jones, Roux, Standcliff, Matthews, & Comer, 2014) Documentation 47 Policies and procedures Clinician agreements and non-patient specific orders Log: name or record number, date, trainer, naloxone dispenser, prescriber, type of kit Add a section for people receiving training (blue card) but not naloxone Inventory records Reversal reports Logistics 48 May be carried by people 16 years or older. Need to obtain from a licensed prescriber or authorized trainer. Should be stored at room temperature and away from direct light (in kit is OK). Has a limited shelf life. Note expiration date and obtain replacement. 16

17 Label 49 Name of recipient Naloxone preparation and formulation Date of receipt Name of program Name of prescriber Name of person furnishing naloxone (not required) Things Needed to Do the Training 50 A naloxone kit for demonstration Blue Certification Cards Informational materials: device assembly instructions, fact sheets, brochures Optional: Dummy to demonstrate rescue breathing. Optional: Orange for injection Practice if using IM naloxone. 51 Trained Overdose Responder Responsibilities Complete refresher training at least every 2 years Contact EMS if suspected drug overdose and advise if naloxone was used Report all naloxone administrations to program director and get a refill 17

18 Non-patient specific order 52 Allows Approved Overdose Trainers to train community members on overdose treatment with naloxone and to furnish the naloxone under the supervision of a doctor, nurse practitioner or physician assistant when the prescriber is not present. 18

Opioid Overdose Prevention Guidelines for Training Responders

Opioid Overdose Prevention Guidelines for Training Responders Opioid Overdose Prevention Guidelines for Training Responders Oct 31, 2006 OD Oct 31, 2006 Opioid Overdose Prevention Guidelines for Training Responders BACKGROUND Introduction Opioid overdose is a serious

More information

OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION

OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION 1.0 Purpose OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION This is a DESC internal operational policy and procedure document [effective date: 06/26/2015] Greg Jensen, Director of Administrative Services

More information

Irish Poet, Rev John Donne

Irish Poet, Rev John Donne No man is an island entire of itself; any man's death diminishes me, because I am involved in mankind therefore never send to know for whom the bell tolls; it tolls for thee. Irish Poet, Rev John Donne

More information

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids

More information

Naloxone treatment of opioid overdose

Naloxone treatment of opioid overdose Naloxone treatment of opioid overdose Opioids Chemicals that act in the brain to relieve pain, often use to suppress cough, treat addiction, and provide comfort After prolonged use of opioids, increasing

More information

Naloxone Distribution for Opioid Overdose Prevention

Naloxone Distribution for Opioid Overdose Prevention Naloxone Distribution for Opioid Overdose Prevention Caleb Banta-Green PhD, MPH, MSW Alcohol and Drug Abuse Institute, University of Washington Alan Melnick, MD, MPH Clark County Public Health Chris Humberson,

More information

Community based opioid overdose prevention: the role of naloxone. William Matthews, Physician Assistant Harm Reduction Coalition New York, NY

Community based opioid overdose prevention: the role of naloxone. William Matthews, Physician Assistant Harm Reduction Coalition New York, NY Community based opioid overdose prevention: the role of naloxone William Matthews, Physician Assistant Harm Reduction Coalition New York, NY Drug poisoning death rates by manner of death, US, 1979 2002

More information

Medications to address the opioid crisis - methadone, buprenorphine, naltrexone, and naloxone

Medications to address the opioid crisis - methadone, buprenorphine, naltrexone, and naloxone Medications to address the opioid crisis - methadone, buprenorphine, naltrexone, and naloxone Alexander Y. Walley, MD, MSc Director, Addiction Medicine Fellowship and Addiction Medicine Consult Service

More information

ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E

ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use

More information

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015 Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol New Mexico Pharmacists Association & Project ECHO 2014 This training fulfills the educational requirement for pharmacists in

More information

Naloxone Rescue for Opioid Reversal

Naloxone Rescue for Opioid Reversal Naloxone Rescue for Opioid Reversal Shannon Panther, PharmD, BCACP Washington State University October 8, 2015 Disclosures No relationships to disclose Intranasal use of naloxone is off label Objectives

More information

A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL

A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL Purpose: To reduce morbidity and mortality from opioid overdose. Policy: Under

More information

Opioid Overdose and Intranasal Naloxone Training for Law Enforcement

Opioid Overdose and Intranasal Naloxone Training for Law Enforcement Opioid Overdose and Intranasal Naloxone Training for Law Enforcement Participant Manual Prepared by NYS Division of Criminal Justice Services NYS Department of Health NYS Office of Alcoholism and Substance

More information

Naloxone: Overview, Criminal Justice and other Special Settings

Naloxone: Overview, Criminal Justice and other Special Settings Naloxone: Overview, Criminal Justice and other Special Settings Ingrid Binswanger, MD, MPH, MS Division of General Internal Medicine Affiliated Member, Division of Substance Dependence University of Colorado

More information

Treatment of opioid use disorders

Treatment of opioid use disorders Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence

More information

TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013

TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,

More information

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS Overview The goal of this presentation is to help inform the public safety community of North Carolina

More information

Opioid overdose can occur when a patient misunderstands the directions

Opioid overdose can occur when a patient misunderstands the directions Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription

More information

OPIOID OVERDOSE PREVENTION ORIENTATION WHAT ARE OPIOIDS AND HOW LONG DO THEY WORK? Duration of Action of Opioids

OPIOID OVERDOSE PREVENTION ORIENTATION WHAT ARE OPIOIDS AND HOW LONG DO THEY WORK? Duration of Action of Opioids OPIOID OVERDOSE PREVENTION ORIENTATION There has been an alarming increase in the incidence of deaths caused by opioid overdose (prescription and non- prescription) in the United States. Enhanced educational

More information

Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013

Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013 Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi Signe Shackelford, MPH Policy Analyst November 19, 2013 Center for Mississippi Health Policy Independent, non-profit organization

More information

Opioid Analgesics. Week 19

Opioid Analgesics. Week 19 Opioid Analgesics Week 19 Analgesic Vocabulary Analgesia Narcotic Opiate Opioid Agonist Antagonist Narcotic Analgesics Controlled substances Opioid analgesics derived from poppy Opiates include morphine,

More information

First on the Scene: People Who Use Drugs, their Families and their Friends. Sharon Stancliff, MD, FAAFP Harm Reduction Coalition New York, NY

First on the Scene: People Who Use Drugs, their Families and their Friends. Sharon Stancliff, MD, FAAFP Harm Reduction Coalition New York, NY First on the Scene: People Who Use Drugs, their Families and their Friends Sharon Stancliff, MD, FAAFP Harm Reduction Coalition New York, NY A brief history with a common theme Chicago 1996: Chicago Recovery

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

International Overdose Awareness Day August 31, 2015

International Overdose Awareness Day August 31, 2015 International Overdose Awareness Day August 31, 2015 Statewide TASC Substance Abuse Evaluators Educational Presentation Jayne Cavanaugh, New Jersey Drug Courts Prevalence of Overdose Deaths per Centers

More information

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA

More information

DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES

DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES 1 DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES PURPOSE To provide guidelines for staff response when a client is found unconscious or not breathing. APPLICABILITY

More information

Overdose Response Training

Overdose Response Training Overdose Response Training In collaboration with the Massachusetts Department of Public Health, Bureau of Substance Abuse Services and Office of HIV/AIDS The Overdose Problem National & regional drug threat

More information

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid

More information

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Sidarth Wakhlu,M.D. Addiction Team Leader North Texas VA Health Care System Addiction Psychiatry Fellowship Director Associate Professor Of Psychiatry

More information

Overdose Prevention and Management in Opioid Treatment Programs

Overdose Prevention and Management in Opioid Treatment Programs Overdose Prevention and Management in Opioid Treatment Programs AATOD 2010 1:30pm Tuesday, October 26, 2010 Moderator: Amina Chaudhry Faculty: Melinda Campopiano Maya Doe-Simkins Alexander Y. Walley Disclosures

More information

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by

More information

DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM

DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM DEVELOPING MANUFACTURING SUPPLYING Naltrexone Implants Background to Nalpharm NalPharm is a specialist pharmaceutical company supplying proprietary branded medications and generic drugs in the area of

More information

JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.

JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii. THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. % RELATING TO DRUG OVERDOSE PREVENTION BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION. The legislature

More information

PRESCRIPTION PAINKILLER OVERDOSES

PRESCRIPTION PAINKILLER OVERDOSES IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky

More information

Heroin Addiction. Kim A. Drury RN, MSN

Heroin Addiction. Kim A. Drury RN, MSN Heroin Addiction Kim A. Drury RN, MSN Heroin use is on the rise in our area. Nearly every day the news media reports situations involving Heroin. According to the Substance Abuse and Mental Health Services

More information

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School OPIOIDS Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School Rutgers New Jersey Medical School Fundamentals of Addiction Medicine Summer Series Newark, NJ July 24, 2013

More information

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management Dr. Barbara Krantz Medical Director Diplomate American Board of Addiction Medicine 1 Learning Objectives

More information

RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING

RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING [R23-1-OPOIDR] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH April 2014 (E) COMPILER S NOTES: Proposed Additions: The

More information

OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E

OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E Sales of opioids: Michigan is above the median in

More information

Abstral Prescriber and Pharmacist Guide

Abstral Prescriber and Pharmacist Guide Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of

More information

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH. Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF

More information

Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment

Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment Testimony of Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment New York City Department of Health and Mental Hygiene before the New York City

More information

OVERVIEW OF MEDICATION ASSISTED TREATMENT

OVERVIEW OF MEDICATION ASSISTED TREATMENT Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest

More information

A G U I D E F O R U S E R S N a l t r e x o n e U

A G U I D E F O R U S E R S N a l t r e x o n e U A GUIDE FOR USERS UNaltrexone abstinence not using a particular drug; being drug-free. opioid antagonist a drug which blocks the effects of opioid drugs. dependence the drug has become central to a person

More information

Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium

Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@case.edu

More information

Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director

Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director Illicit Drugs Marijuana Prescription Drug Misuse/Abuse is a Major Problem in the US Current

More information

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and

More information

Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction

Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently

More information

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction

More information

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This

More information

Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Gateway Rehabilitation Center

Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Gateway Rehabilitation Center PRESCRIPTION DRUG ABUSE, HEROIN ADDICTION AND OVERDOSE PREVENTION IN RURAL COMMUNITIES Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Gateway Rehabilitation Center Number of Deaths from Drug Overdoses

More information

A prisoners guide to buprenorphine

A prisoners guide to buprenorphine A prisoners guide to buprenorphine 2 The Opium poppy In the land of far, far away the opium poppy grows. The seed pods of this poppy are scratched until they drip with a sticky resin called opium. Raw

More information

Presentation by: Commissioner E. Douglas Varney

Presentation by: Commissioner E. Douglas Varney Presentation by: Commissioner E. Douglas Varney Prescription Drug Abuse Affects Everyone Families as a whole Women Children The abuse of prescription drugs, particularly opioids, is costly not only for

More information

The Opiate Epidemic. Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT

The Opiate Epidemic. Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT The Opiate Epidemic Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT Connections Counseling Madison, WI www.connectionscounseling.com The Opiate Epidemic Opioid-related Facts

More information

OPIOIDS: ADDICTION, OVERDOSE PREVENTION (NALOXONE) AND PATIENT EDUCATION

OPIOIDS: ADDICTION, OVERDOSE PREVENTION (NALOXONE) AND PATIENT EDUCATION OPIOIDS: ADDICTION, OVERDOSE PREVENTION (NALOXONE) AND PATIENT EDUCATION University of Rhode Island College of Pharmacy Continuing Professional Education Created by: Tara Thomas, PharmD 13 Narrated by:

More information

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health? Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown

More information

10/28/2014. Collecting the Raw Opium

10/28/2014. Collecting the Raw Opium Opioid Analgesics (or Narcotic Analgesics) We are moving on to a new category of drugs whose effects, superficially, may look similar to those of the CNS depressants, but the drugs are, in fact, a completely

More information

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health? Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown

More information

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9 Table of Contents I. Introduction... 2 II. Summary... 3 III. Charts A. Total Drug Intoxication Deaths... 5 B. Opioid-Related Deaths... 9 C. Heroin-Related Deaths... 11 D. Prescription Opioid-Related Deaths...

More information

Heroin in Snohomish County: Mortality and Treatment Trends

Heroin in Snohomish County: Mortality and Treatment Trends Heroin in Snohomish County: Mortality and Treatment Trends January 2015 This page left intentionally blank. Table of Contents Introduction and Acknowledgments 1 Executive Summary 2 Mortality Overdose Mortality

More information

Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?

Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain? Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears

More information

P U B L I C H E A L T H A D V I S O R Y

P U B L I C H E A L T H A D V I S O R Y The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619Tel: 617-624-6000 Fax: 617-624-5206 www.mass.gov/dph

More information

- NALOXONE/NARCAN. This training is designed to teach you about one action you can take in case of an overdose of opiates.

- NALOXONE/NARCAN. This training is designed to teach you about one action you can take in case of an overdose of opiates. OVERDOSE MANAGEMENT PROTOCOL - NALOXONE/NARCAN TRAINING This training is designed to teach you about one action you can take in case of an overdose of opiates. This training program will not make you a

More information

Use of Vivitrol for Alcohol and Opioid Addiction

Use of Vivitrol for Alcohol and Opioid Addiction Use of Vivitrol for Alcohol and Opioid Addiction Ken Bachrach, Ph.D. Clinical Director, Tarzana Treatment Centers, Inc. kbachrach@tarzanatc.org What is Vivitrol? An injectable from of naltrexone, which

More information

Blueprint for Prescriber Continuing Education Program

Blueprint for Prescriber Continuing Education Program CDER Final 10/25/11 Blueprint for Prescriber Continuing Education Program I. Introduction: Why Prescriber Education is Important Health care professionals who prescribe extended-release (ER) and long-acting

More information

This booklet provides information for people who use heroin The National Drug and Alcohol Research Centre (NDARC) has conducted many interviews with

This booklet provides information for people who use heroin The National Drug and Alcohol Research Centre (NDARC) has conducted many interviews with This booklet provides information for people who use heroin The National Drug and Alcohol Research Centre (NDARC) has conducted many interviews with heroin users, many of whom have requested more information

More information

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,

More information

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational

More information

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents Teen Misuse and Abuse of Alcohol and Prescription Drugs Information for Parents Terminology Misuse: Using a drug in a way in which it was not intended Example: Using a higher dose of medication than was

More information

Update on Buprenorphine: Induction and Ongoing Care

Update on Buprenorphine: Induction and Ongoing Care Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference

More information

Medications for Alcohol and Drug Dependence Treatment

Medications for Alcohol and Drug Dependence Treatment Medications for Alcohol and Drug Dependence Treatment Robert P. Schwartz, M.D. Medical Director Rschwartz@friendsresearch.org Friends Research Institute Medications for Alcohol Dependence Treatment Disulfiram

More information

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER November 17, 2015 Today s Speakers Karmen Hanson, Program Manager, NCSL Cynthia Reilly, Director,

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

Objectives. Background

Objectives. Background Development and Implementation of a Pharmacist-Managed Intranasal Naloxone Distribution Program in a Veterans Affairs Healthcare Facility and Associated Community Clinics Innovative Practices Award Finalist

More information

Populations at risk for opioid overdose

Populations at risk for opioid overdose Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April

More information

The ABCs of Medication Assisted Treatment

The ABCs of Medication Assisted Treatment The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment

More information

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate

More information

Outline. Interventions to Reduce Opioid Overdose State of the Art 9/23/2013

Outline. Interventions to Reduce Opioid Overdose State of the Art 9/23/2013 Interventions to Reduce Opioid Overdose State of the Art Caleb J. Banta Green PhD MPH MSW Research Scientist Alcohol and Drug Abuse Institute Affiliate Asst. Professor School of Public Health University

More information

Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century

Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century Mother s little helper: Prescription drug abuse in the 21 st century Carol Falkowski CEO and Founder Drug Abuse Dialogues St. Paul, Minnesota www.drugabusedialogues.com More kids smoke marijuana than smoke

More information

One example: Chapman and Huygens, 1988, British Journal of Addiction

One example: Chapman and Huygens, 1988, British Journal of Addiction This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman

More information

APPENDIX: Key summary of six US-based naloxone distribution programs

APPENDIX: Key summary of six US-based naloxone distribution programs Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six naloxone training and distribution programs in the United States Traci C. Green, Robert Heimer, Lauretta E. Grau

More information

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data Volume #1 October 2015 PUBLIC HEALTH ISSUE BRIEF Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data October 2015 Partners for a Healthier Community, Inc.

More information

Version Number: 5. Patient Group Direction originally drawn up by: Reviewed by: Patient Group direction authorised by: Medical Lead

Version Number: 5. Patient Group Direction originally drawn up by: Reviewed by: Patient Group direction authorised by: Medical Lead PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY AND/OR ADMINISTRATION OF NALOXONE HYDROCHLORIDE INJECTION BY REGISTERED NURSES WORKING IN COMMUNITY AND INPATIENT SUBSTANCE MISUSE TEAMS Version Number: 5 Patient

More information

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,

More information

The Current State of Drug Abuse Across the Nation. December 12, 2015

The Current State of Drug Abuse Across the Nation. December 12, 2015 The Current State of Drug Abuse Across the Nation December 12, 2015 Agenda The Partnership for Drug-Free Kids The macro picture Opioid abuse and addiction What can we do about it? Moving upstream: connecting

More information

Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County

Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County Cuyahoga County March 2014, Issue 1 Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County According to the Ohio Department of Health (ODH), between 1999 and 2011,

More information

New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015**

New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015** New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015** Disclaimer This presentation was created to assist in the education of EMTs in Naloxone administration.

More information

Education. The Council of Southeast Pennsylvania, Inc. Overdose Prevention and. Education Advisory Board

Education. The Council of Southeast Pennsylvania, Inc. Overdose Prevention and. Education Advisory Board Overdose Prevention and Education The Council of Southeast Pennsylvania, Inc. Overdose Prevention and Education Advisory Board Outline What is an Overdose? What drugs are we talking about? Risk Factors

More information

Drug Abuse Trends in the Seattle/King County Area: 2013

Drug Abuse Trends in the Seattle/King County Area: 2013 Drug Abuse Trends in the Seattle/King County Area: 2013 Caleb Banta-Green 1, T. Ron Jackson 2, Steve Freng 3, Michael Hanrahan 4, Cynthia Graff 5, John Ohta 6, Mary Taylor 7, Richard Harruff 8, Robyn Smith

More information

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Dale K. Adair, MD Medical Director/Chief Psychiatric Officer OMHSAS 1 Treatment and Interventions for

More information

Prescription Opioid Overdose & Misuse in Oregon

Prescription Opioid Overdose & Misuse in Oregon Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon In-State Policy Workshop NGA Policy Academy: Reducing

More information

Prescription Drugs: Abuse and Addiction

Prescription Drugs: Abuse and Addiction EAP Drug Free Workplace Newsletter March 2014 Prescription Drugs: Abuse and Addiction What are some of the commonly abused prescription drugs? Although many prescription drugs can be abused or misused,

More information

This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name.

This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name. Welcome! 1 This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name. 2 Definitive treatment for an opioid or opiate overdose

More information

Using Buprenorphine in an Opioid Treatment Program

Using Buprenorphine in an Opioid Treatment Program Using Buprenorphine in an Opioid Treatment Program Thomas E. Freese, PhD Director of Training, UCLA Integrated Substance Abuse Programs Director, Pacific Southwest Addiction Technology Transfer Center

More information

How To Treat Anorexic Addiction With Medication Assisted Treatment

How To Treat Anorexic Addiction With Medication Assisted Treatment Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious

More information

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org Disclosures Project Lazarus Zogenix Charitable Contribution 2015 Kaléo Charitable Contribution

More information

Opioid/Opiate Dependent Pregnant Women

Opioid/Opiate Dependent Pregnant Women Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San

More information

Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD

Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem Thomas Kosten MD Waggoner Chair & Professor of Psychiatry & Neuroscience Baylor College of Medicine Past-President,

More information

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,

More information